XML 34 R16.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes
12 Months Ended
Dec. 31, 2024
Income Taxes  
Income Taxes

8. Income Taxes

The provision for income taxes for the years ended December 31 consists of the following:

(thousands)

    

2024

    

2023

    

2022

Current:

 

  

 

  

 

  

Federal

$

(8,586)

$

33,832

$

139,730

State

 

3,352

 

16,108

 

29,117

International

 

200,912

 

299,031

 

293,195

$

195,678

$

348,971

$

462,042

Deferred:

 

  

 

  

 

  

Federal

$

(50,305)

$

(59,342)

$

(39,658)

State

 

(8,348)

 

(11,960)

 

(5,613)

International

 

(41,213)

 

(22,678)

 

32,221

 

(99,866)

 

(93,980)

 

(13,050)

$

95,812

$

254,991

$

448,992

The principal causes of the difference between the U.S. federal statutory tax rate of 21% and effective income tax rates for the years ended December 31 are as follows:

(thousands)

    

2024

    

2023

    

2022

United States

$

(234,972)

$

(38,848)

$

517,642

International

 

724,291

 

1,203,202

 

1,366,508

Income before income taxes

$

489,319

$

1,164,354

$

1,884,150

Provision at statutory tax rate

$

102,757

$

244,514

$

395,672

State taxes, net of federal benefit

 

(3,279)

 

2,379

 

18,675

International effective tax rate differential

 

8,958

 

27,993

 

26,210

Change in valuation allowance

 

333

 

(7,755)

 

(6,378)

Other non-deductible expenses

 

(585)

 

2,993

 

7,441

Changes in tax accruals

 

(9,419)

 

1,153

 

5,993

Tax credits

 

(10,786)

 

(7,666)

 

980

U.S. tax (benefit) on foreign earnings

6,801

(10,075)

3,879

Other

 

1,032

 

1,455

 

(3,480)

Provision for income taxes

$

95,812

$

254,991

$

448,992

The company is subject to taxation of GILTI on foreign subsidiaries and a tax provision to deduct a portion of FDII of U.S. corporations. GILTI tax expense, accounted for as a current period cost, net of FDII benefit, resulted in a net tax expense (benefit) of $4.7 million, $23.0 million, and $(7.4) million during 2024, 2023, and 2022, respectively.

At December 31, 2024, a short-term tax payable of $6.9 million was recorded in the consolidated balance sheets for a one-time transition tax on the foreign subsidiaries’ accumulated unremitted earnings related to the 2017 U.S. Tax Cuts and Jobs Act.

At December 31, 2024, the company had a liability for unrecognized tax positions of $64.0 million. The timing of the resolution of these uncertain tax positions is dependent on the tax authorities’ income tax examination processes. Material changes are not expected; however, it is possible that the amount of unrecognized tax benefits with respect to uncertain tax positions could increase or decrease during 2025. Currently, the company is unable to make a reasonable estimate of when cash settlement would occur and how it would impact the effective tax rate.

A reconciliation of the beginning and ending amount of unrecognized tax benefits for the years ended December 31 is as follows:

(thousands)

    

2024

    

2023

    

2022

Balance at beginning of year

$

82,808

$

75,666

$

71,422

Additions based on tax positions taken during a prior period

 

4,537

 

7,466

 

6,760

Reductions based on tax positions taken during a prior period

 

(20,245)

 

(4,448)

 

(3,007)

Additions based on tax positions taken during the current period

 

7,943

 

5,505

 

3,526

Reductions related to settlement of tax matters

 

(11,090)

 

 

(2,271)

Reductions related to a lapse of applicable statute of limitations

 

 

(1,381)

 

(764)

Balance at end of year

$

63,953

$

82,808

$

75,666

Interest costs related to unrecognized tax benefits are classified as a component of “Interest and other financing expense, net” in the company’s consolidated statements of operations. In 2024, 2023, and 2022, the company recognized $5.9 million, $4.0 million, and $4.4 million, respectively, of interest expense related to unrecognized tax benefits. At December 31, 2024 and 2023, the company had accrued a liability of $23.5 million and $17.5 million, respectively, for interest related to unrecognized tax benefits.

In many cases the company’s uncertain tax positions are related to tax years that remain subject to examination by tax authorities. The following describes the open tax years, by major tax jurisdiction, as of December 31, 2024:

United States - Federal

    

2016 - present

United States - States

 

2015 - present

Germany (a)

 

2020 - present

China and Hong Kong

 

2017 - present

Italy (a)

 

2013 - present

Netherlands

 

2018 - present

Sweden

 

2019 - present

Taiwan

 

2018 - present

United Kingdom

 

2020 - present

(a)Includes federal as well as local jurisdictions.

Deferred income taxes are provided for the effects of temporary differences between the tax basis of an asset or liability and its reported amount in the consolidated balance sheets. These temporary differences result in taxable or deductible amounts in future years.

Deferred tax assets and liabilities consist of the following at December 31:

(thousands)

    

2024

    

2023

Deferred tax assets:

 

  

 

  

Net operating loss carryforwards

$

16,567

$

17,987

Inventory adjustments

 

110,370

 

68,542

Allowance for credit losses

 

20,475

 

27,637

Accrued expenses

 

86,964

 

73,251

Interest carryforward

 

21,923

 

4,170

Stock-based compensation awards

 

5,490

 

5,692

Lease liability

 

65,718

 

68,605

Research and experimentation costs (a)

 

73,971

 

59,277

Other

 

992

 

3,332

 

402,470

 

328,493

Valuation allowance

 

(16,165)

 

(15,832)

Total deferred tax assets

$

386,305

$

312,661

Deferred tax liabilities:

 

  

 

  

Goodwill

$

(157,786)

$

(152,551)

Depreciation

 

(42,540)

 

(58,419)

Lease right-of-use assets

 

(61,685)

 

(64,937)

Other comprehensive income items

 

(15,615)

 

(13,204)

Total deferred tax liabilities

$

(277,626)

$

(289,111)

Total net deferred tax assets

$

108,679

$

23,550

(a)At December 31, 2024, and 2023, the company recorded deferred tax asset of $74.0 million and $59.3 million related to capitalized U.S. based research and experimental (“R&E”) costs, pursuant to the U.S. Internal Revenue Code Section 174, as amended by the 2017 U.S. Tax Cuts and Jobs Act.

At December 31, 2024, the company had international tax loss carryforwards of approximately $30.3 million, of which $7.0 million have expiration dates ranging from 2025 to 2044, and the remaining $23.3 million have no expiration date. Deferred tax assets related to these international tax loss carryforwards were $7.8 million with a corresponding valuation allowance of $2.6 million. At December 31, 2024, the company had a valuation allowance of $0.1 million related to other deferred tax assets.

At December 31, 2024, the company had deferred tax assets of approximately $8.7 million with a corresponding valuation allowance of $6.4 million, related to U.S. state net operating loss carryforwards. Valuation allowances are needed when deferred tax assets may not be realized due to the uncertainty of the timing and the ability of the company to generate sufficient future taxable income in certain tax jurisdictions.

At December 31, 2024, the company had approximately $5.4 billion in undistributed foreign earnings which it deems to be indefinitely reinvested, and approximately $2.0 billion in undistributed foreign earnings which it deems to be not permanently reinvested. The company recognizes that if it reverses its indefinite reinvestment assertion on $5.4 billion of foreign earnings, it may be subject to additional foreign taxes and U.S. state income taxes.

Income taxes paid, net of income taxes refunded, amounted to $230.5 million, $538.4 million, and $384.4 million in 2024, 2023, and 2022, respectively.